NCT03596060 is a NA clinical trial of Fentanyl in Hip Fractures, sponsored by Larissa University Hospital.

Who is sponsoring NCT03596060?

NCT03596060 is sponsored by Larissa University Hospital.

What drugs are being tested in NCT03596060?

Interventions in NCT03596060: Fentanyl, Propofol, Rocuronium, Chirochaine, Morphine.

What condition does NCT03596060 study?

NCT03596060 studies Hip Fractures.

Is NCT03596060 still recruiting?

NCT03596060 is currently status unknown. Last updated 26 September 2021.

Last reviewed 2021-09-26 · How we verify

NCT03596060

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Regional vs General Anesthesia in Patients With Hip Fracture Under Treatment With Clopidogrel

Status unknown NA Last updated 26 September 2021

What this trial tests

NA trial testing Fentanyl in Hip Fractures in 150 participants. Status unknown.

Timeline

20 October 2017

Primary endpoint
1 May 2022

1 October 2022

Quick facts

Lead sponsor	Larissa University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	150
Start date	20 October 2017
Primary completion	1 May 2022
Estimated completion	1 October 2022
Sites	1 location across Greece

Drugs / interventions tested

Fentanyl (fentanyl) — full drug profile →
Propofol (Propofol) — full drug profile →
Rocuronium (ROCURONIUM) — full drug profile →
Chirochaine — full drug profile →
Morphine

Conditions studied

Hip Fractures — all drugs for Hip Fractures →

Sponsor

Larissa University Hospital

Who can join

Adults 65 to 100, any sex, with Hip Fractures. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Mortality
Time frame: 30 days
To compare postoperative 30-day mortality between General anesthesia and Regional anesthesia group

Sponsor's own description

This study compares general to regional anesthesia concerning morbidity and mortality in patients older than or equal to 65 years old who receive clopidogrel and are to be submitted in hip fracture surgery. Half of participants will receive general anesthesia the first 48 hours and the other half will receive regional anesthesia after 5 days of the discontinuation of clopidogrel.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Fentanyl

Trials testing the same drug.

NCT07435337 — Effect of Nalbuphine Versus Fentanyl on Hemdoynamic Effects of Laryngoscopy · Phase 4 · recruiting
NCT07276867 — Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia f · NA · recruiting
NCT06763705 — Comparison of Safety and Efficacy for Different Sedation Regimens During Colonoscopy · Phase 4 · recruiting
NCT06772727 — Lidocaine-based Versus Opioid-based Induction of Anesthesia in Emergency Laparotomy · Phase 4 · completed
NCT06561672 — Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries · EARLY_PHASE1 · enrolling by invitation

Other recruiting trials for Hip Fractures

Currently open trials in the same condition.

NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
NCT07002723 — Effects of Esketamine Combined With Dexmedetomidine on Postoperative Sleep Quality · NA · recruiting
NCT06893406 — Cervical Myelopathy in Hip Fracture Patients · NA · recruiting
NCT06565910 — Bupivacaine Liposome Plus Bupivacaine or Ropivacaine for Pericapsular Nerve Group Block in Hip Arthroplasty (PENG) · Phase 4 · recruiting
NCT06455813 — What Laxative Should be Used After Hip Fracture Surgery? · Phase 4 · recruiting

Other Larissa University Hospital trials

Trials by the same sponsor.

NCT07402005 — The Correlation of Lewis Antigens With VTE · not yet recruiting
NCT07162324 — A Multicenter, Prospective Study for Glioblastoma Patients · not yet recruiting
NCT07412301 — The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study · active not recruiting
NCT07066566 — The Effect of Asymmetrical vs. Symmetrical High Flow Nasal Cannula on the Work of Breathing · NA · recruiting
NCT05829083 — DUET Versus Standard Interface for Hypercapnic COPD Patients · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03596060 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Larissa University Hospital
Last refreshed: 26 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03596060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing